Adult Enteral Nutrition Clinical Practice Guideline

1. Introduction

Enteral nutrition (EN) is the preferred method of providing nutrients to patients who cannot meet their requirements by oral intake but have a functional gastrointestinal (GI) tract. The Adult Enteral Nutrition Clinical Practice Guideline (CPG) offers evidencebased recommendations to ensure safe, effective, and patientcentred delivery of EN across acute, subacute, and community settings.

The guideline is intended for physicians, dietitians, nurses, pharmacists, speechlanguage pathologists, and other healthcare professionals involved in the assessment, prescription, delivery, and monitoring of enteral feeds.

2. Scope and Target Population

The CPG applies to adults (18years) who require enteral feeding for any indication, including:

• Neurological disorders (stroke, traumatic brain injury, neurodegenerative disease)
• Critical illness and intensive care unit (ICU) patients
• Gastrointestinal surgery and obstruction
• Cancer and palliative care
• Chronic illnesses such as chronic obstructive pulmonary disease (COPD) and heart failure

Patients with a nonfunctioning GI tract (e.g., highgrade intestinal failure) are excluded and should be managed with parenteral nutrition according to separate guidelines.

3. Guiding Principles

The following principles underpin the guideline:

• Patientcentred care: Decisions should incorporate patient preferences, goals of care, and qualityoflife considerations.
• Evidencebased practice: Recommendations are graded according to the strength of supporting evidence (GRADE system).
• Multidisciplinary collaboration: Effective EN requires coordinated input from the whole healthcare team.
• Safety and risk management: Early identification of complications and proactive prevention strategies are essential.

4. Assessment Prior to Initiation

4.1 Nutritional Assessment

A systematic nutritional assessment should be performed using validated tools (e.g., MUST, NRS2002). Key elements include:

• Weight history and bodymass index (BMI)
• Recent dietary intake and severity of undernutrition
• Laboratory markers (albumin, prealbumin, CRP) as adjuncts
• Functional status and comorbidities

4.2 Gastrointestinal Function

Confirm that the GI tract is capable of handling enteral feeds. Assess presence of:

• Upper GI obstruction or fistula
• Severe motility disorders
• Uncontrolled vomiting or severe gastrooesophageal reflux

4.3 Airway Protection

Patients at risk of aspiration (e.g., impaired cough, altered consciousness) need a swallowing assessment by a qualified speechlanguage pathologist before oral or nasogastric (NG) feeding.

5. Choice of Feeding Route

The selection of feeding route follows the hierarchy of least invasive to most invasive, prioritising patient comfort and safety.

• Oral nutrition with supplements first line when feasible.
• Nasogastric (NG) tube appropriate for shortterm (<46weeks) feeding.
• Nasoduodenal or nasojejunal tube indicated when gastric feeding is contraindicated (e.g., high aspiration risk, delayed gastric emptying).
• Gastrostomy (PEG, radiologically inserted gastrostomy) preferred for anticipated feeding >46weeks.
• Jejunostomy when gastric feeding is not tolerated or contraindicated longterm.

6. Prescription of Enteral Feed

6.1 Determining Energy and Protein Targets

Recommended calculations (adjusted for stress and activity):

• Energy: 2530kcal/kg actual body weight per day (3035kcal/kg for critically ill patients).
• Protein: 1.22.0g/kg/day (up to 2.5g/kg for severe catabolism).

6.2 Choice of Formula

Formula selection should be based on clinical condition:

• Standard polymeric formulas for patients with normal digestion and absorption.
• Elemental or semielemental formulas for malabsorption, severe pancreatitis, or high aspiration risk.
• Highprotein, highenergy, diseasespecific (e.g., renal, diabetic) formulas when a specific metabolic need exists.

6.3 Initiation Protocols

Two widely used methods:

• Continuous feeding: Start at 1020mL/h, increase by 1020mL/h every 46h to target rate, usually over 24h.
• Intermittent (bolus) feeding: 200400mL per bolus, 46 times daily, appropriate for patients with functional gastric emptying.

7. Monitoring and Ongoing Assessment

Monitoring should be systematic and documented.

7.1 Clinical Monitoring

• Daily check of tube position (length markings, aspiration of gastric content).
• Assessment for signs of aspiration (cough, wheeze, chest infiltrates).
• Evaluation of feeding tolerance abdominal distension, nausea, vomiting, diarrhoea.
• Weight measured at least weekly.

7.2 Laboratory Monitoring

• Baseline and weekly electrolyte panel (Na, K, Cl, Mg, PO4).
• Blood glucose daily for the first week, then 23 times weekly.
• Serum triglycerides if lipidcontaining formulas are used.
• Renal and liver function tests as indicated.

7.3 Adjustments

Modify rate, concentration, or formula based on tolerance, metabolic parameters, and evolving clinical status.

8. Prevention and Management of Complications

8.1 Mechanical Complications

• Tube displacement secure with appropriate fixation devices and verify placement before each feed.
• Obstruction flush the tube with 2030mL water before and after each feeding; use enzymatic agents if needed.

8.2 Gastrointestinal Complications

• Diarrhoea evaluate for infection, osmolarity of formula, and medications; consider fiberenhanced formulas.
• Constipation ensure adequate fluid intake, consider osmotic laxatives.
• Refeeding syndrome start low (510kcal/kg) in severely malnourished patients, correct electrolytes preemptively.

8.3 Metabolic Complications

• Hyperglycaemia use insulin protocols; consider diabeticspecific formulas.
• Hypertriglyceridaemia limit lipid provision, switch to mediumchain triglyceride (MCT) or lipidfree formulas.

8.4 Aspiration

Implement strategies such as headofbed elevation 30, postpyloric feeding, and continuous rather than bolus feeding for highrisk patients.

9. Discharge Planning and Continuity of Care

Transition from hospital to home or longterm care should include:

• A written care plan detailing formula type, rate, and equipment.
• Education for patients, families, and caregivers on tube handling, feeding procedures, and signs of complications.
• Followup appointments with dietitian and nursing staff within 12weeks of discharge.

Home health services may be required for complex cases, especially when a jejunostomy or PEG tube is in place.

10. Ethical Considerations

Enteral nutrition may be initiated, continued, or withdrawn based on patient autonomy, prognosis, and qualityoflife goals. Advance directives and discussions with the patient or surrogate decisionmaker should be documented before making decisions that affect the continuation of EN.

11. Summary of Key Recommendations

1. Perform a comprehensive nutritional and GI assessment before initiating EN.
2. Choose the least invasive feeding route appropriate for the expected duration.
3. Prescribe energy and protein targets individualized to stress level and comorbidities.
4. Monitor clinical status, weight, electrolytes, and glucose regularly; adjust the regimen promptly.
5. Implement systematic strategies to prevent aspiration and mechanical complications.
6. Provide clear discharge instructions and arrange timely followup.

12. References

1. American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient. 2023.

2. European Society for Clinical Nutrition and Metabolism (ESPEN). Clinical Nutrition in the Adult Patient: Guidelines. 2022.

3. Singer P, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2021.

4. McClave SA, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Patient. J Parenter Enteral Nutr. 2020.

5. NICE. Enteral tube feeding: Nutrition support in adults. NG33. Updated 2021.